Bristol Myers Squibb has sued the Biden administration over payment terms for hospitals in the 340B Drug Discount Program.

Bhattacharya would be in charge of Trump's bold goals to reform the NIH, which spends billions to fund medical research.

President-elect Trump has nominated biotech investor Jim O’Neill for deputy secretary of the Health and Human Services ...

The Biden administration is proposing a major expansion of how Medicare and Medicaid cover the weight-loss drugs Wegovy and ...

Opinion: Low pay, high pressure, a troubling political landscape — it’s all leading to medical students electing not to ...

I spent four crazy years writing about Cassava Sciences, Adam Feuerstein writes. Yesterday, the story ended exactly as many ...

Health officials in British Columbia, Canada, have failed, for now, to confirm how a teenager there became infected with H5N1 ...

The law is intended to crack down on Chinese biotech companies, but it may become more difficult to pass next year.

An Amgen obesity drug helped participants lose a substantial amount of weight, but questions about how competitive it could ...

Marty Makary, a Johns Hopkins surgeon and outspoken critic of parts of the U.S. medical system, is Trump’s pick for FDA ...

Will the Novo-Catalent merger be challenged under the new Trump administration? A former FTC policy director thinks so.

A cancer treatment from Roche failed to improve survival in a major lung cancer study, a result that will stoke doubts about ...